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Abstract: Since the United States Food and Drug Administration’s approval of over-the-counter
levonorgestrel emergency contraception, access to this time-sensitive medication has improved.
However, multiple barriers, including the cost of the medication and pharmacy availability, still exist.
The objective of this study was to determine the over-the-counter availability of levonorgestrel
emergency contraception in pharmacies on Oahu, Hawaii. We conducted a cross-sectional
population-based study using in-person simulated patient encounters at all pharmacies on Oahu.
Out of 109 chain pharmacies and 13 independent pharmacies, 102 (84%) pharmacies had levonorgestrel
emergency contraception available over the counter. Of pharmacies in which it was available,
12.7% required an employee to unlock the medication, 37.3% required the medication to be
unlocked at the register, 29.4% were packaged in a large plastic box, and 3.9% were packaged
in a blister pack. Levonorgestrel emergency contraception is widely available as an over-the-counter
medication in pharmacies on Oahu, yet there are packaging and display practices that make it less
accessible. Many of these practices could be improved with pharmacy education or changes in store
policies. Systems-based interventions are needed to improve the access to levonorgestrel emergency
contraception as an over-the-counter medication.
Keywords: levonorgestrel; emergency contraception; over-the-counter; pharmacy; simulated patient
1. Introduction
Levonorgestrel emergency contraception (LNG EC) is a medication that can be taken up to 120 h
after unprotected intercourse to avoid pregnancy. Its efficacy is highest when taken immediately after
unprotected intercourse, making immediate availability important [1]. In 2013, the United States Food
and Drug Administration (FDA) approved LNG EC to be available to all people over the counter
(OTC) without a prescription. Although this has increased access to LNG EC, multiple studies have
shown that barriers to access remain. A nationwide study conducted by female mystery callers showed
that 83% of pharmacies had LNG EC available; however, only 51.6% of pharmacies reported correct
information on its OTC access. [2] A study conducted in Colorado found that only 23% of pharmacies
had LNG EC completely accessible, meaning available for purchase without an identification card
or prescription [3]. A study in New York found that males were able to purchase LNG EC OTC
in 80% of attempts, with the others primarily requiring a woman’s presence or her identification
card [4]. Internationally, women face similar barriers to access, including the cost of the medication,
pharmacy availability, age restrictions, and feeling “judged and patronized” after consultation with a
pharmacist [5,6]. While some countries have made EC available in pharmacies or health centers at no
cost, it remains completely unavailable in some countries [7,8]. Access in geographically isolated areas
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can be limited. A telephone study comparing the different islands in Hawaii showed that availability
varied throughout the islands from 0% in Molokai to 82% of pharmacies on Oahu [9].
To improve timely access, the American College of Obstetricians and Gynecologists (ACOG)
recommends that advance prescription of EC be provided to patients [10]. Unfortunately, not all
physician offices and health centers follow this recommendation and not all patients see a provider
prior to unprotected intercourse. Since there are no requirements regarding how OTC medications
are sold, product packaging and placement in pharmacies is important. Locked boxes and storing
the medication behind the pharmacy counter create barriers to access [11]. While a previous study
evaluated LNG EC OTC availability in Oahu pharmacies via telephone, barriers within the pharmacy
setting have not been evaluated. Our study’s primary objective was to determine the OTC availability
of LNG EC in pharmacies on Oahu. Secondary outcomes included cost, packaging, brand availability,
number of staff member encounters experienced for purchase, additional information required for
purchase (such as age, identification, prescription, or insurance card), difficulty obtaining LNG EC,
differences in availability between chain and independent pharmacies, and the accuracy of any
medication information provided.
2. Materials and Methods
Overview: We conducted a cross-sectional population-based study using in-person simulated
patient encounters at all pharmacies on Oahu. Previous pharmacy-based simulated patient studies
have recruited students, trained them in different scenarios via supervised role-play, assigned them
specific pharmacies, and had them record their gathered data immediately after each visit [12,13].
Our study was conducted in a similar manner. The primary researcher created a script and piloted
this script at several pharmacies prior to data collection. This script was then modified based on
preliminary interactions to better simulate real-life scenarios. This modified script was validated by
the other members of the research team. Next, an email was sent out to the Obstetrics and Gynecology
Medical Student Interest Group to recruit simulated patients. Simulated patients then attended a
training session where they were given the background of the study and role-played simulated patient
encounters under direct supervision. They were trained in specific scenarios and in collecting and
recording data. Simulated patients presented themselves as reproductive aged people dressed in
T-shirts and shorts seeking LNG EC OTC between February and March of 2018. Four (44%) of our
shoppers were between the ages of 20–24 years. Three (33%) were between the ages of 25–29 years.
Two (22%) of our shoppers were 30 years old. Eight (88%) of our simulated patients identified as
female and one (11%) identified as male. The simulated patients were allowed to select more than
one ethnicity when reporting their demographics. Our simulated patients reflected the diverse racial
makeup of Hawaii, with two identifying as Filipino, one as Chinese, one as Japanese, one as Caucasian,
one as Hawaiian, one as Korean, one as Caucasian and Korean, and one as Japanese and Caucasian.
The pharmacies were initially divided among simulated patients based on geographic proximity
and preference. The remainder of the pharmacies were then assigned based on simulated patient
availability throughout the study period. The majority of pharmacy visits (42, 34%) were conducted by
the primary researcher. The remainder of the simulated patients conducted 16, 15, 14, 12, 9, 7, 5, and 2
pharmacy visits. Upon entering the pharmacy, simulated patients first attempted to obtain the LNG EC
without assistance. If this was not possible, they then followed a previously rehearsed script to speak
with staff to obtain the LNG EC. Simulated patients were trained using interactive role-play techniques
and data collection protocols prior to entering pharmacies. Each identified pharmacy was visited once.
Samples and settings: This study analyzed all retail pharmacies including community, hospital,
clinic, and Kaiser pharmacies on Oahu in order to capture all locations where a patient may attempt to
purchase LNG EC OTC. The pharmacies were initially identified based on a previous pharmacy-based
EC study on Oahu conducted in 2015 [9]. This list from 2015 was cross-referenced with an online
phonebook, chain pharmacy websites, and an Epic electronic medical record pharmacy list in order to
create an updated list. Inclusion criteria for pharmacies included chain and independent pharmacies
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on the island of Oahu. Exclusion criteria included pharmacies that were permanently closed,
duplicate pharmacies, specialty pharmacies, and pharmacies outside the island of Oahu. A total of 155
pharmacies were identified on Oahu. Of these, 33 pharmacies were excluded: 17 due to permanent
closure, 7 due to duplicate pharmacy information, 8 due to specialty-only status (e.g., antipsychotic
injections only, compounding medications only) without OTC medications available, and 1 due to a
location outside of Oahu. This left 122 pharmacies eligible for inclusion. This is shown in Figure 1.
Independent pharmacies were defined as pharmacies that had a single location. Chain pharmacies
were defined as pharmacies that had more than one location.
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Data collection: All data were collected and recorded immediately after the pharmacy visit using
the REDCap®electronic data capture tool on simulated patients’ mobile devices. The questionnaire
was developed to capture all of the outcome measures of interest for our study. The primary researcher
validated the questionnaire by piloting it at several pharmacies prior to formal data collection.
After initial data collection, the data were reviewed for reliability. The data collection questionnaire and
scales can be seen in the Supplementary Materials. Prior to entering a pharmacy, the simulated patients
recorded the pharmacy name, address, date and time of visit, and status as an independent or chain
pharmacy. In addition, simulated patients recorded their own age, sex, and ethnicity. Upon entering a
pharmacy, the simulated patient attempted to locate the LNG EC. If the LNG EC was readily available
OTC, the simulated patient took a picture of the display, recorded the packaging, price, and brands
available, and picked up the medication and brought it to the cashier. Once at the front store or
pharmacy cashier, the simulated patient recorded any additional information that was asked and
stated that they forgot their wallet. This ended the encounter. If the medication was visible OTC
but required employee assistance, the simulated patient then asked the first available employee for
assistance. If the medication was not visible OTC, the simulated patient asked the first available store
employee for assistance in locating the LNG EC. If the LNG EC was currently out of stock or not
available in the store, the simulated patient asked if the medication could be ordered and how soon it
would be available for purchase in the store. After the encounter, the simulated patient recorded the
number of pharmacy staff encountered, the sexes, roles, and friendliness of each staff member, the
difficulty in obtaining the LNG EC, and the length of time taken to obtain the LNG EC. Standardized
scales were developed for subjective measures including staff friendliness and difficulty obtaining
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medication. The friendliness scale was created based on preliminary pharmacy visits conducted prior
to data collection. The difficulty scale was created with a baseline reference of ease of purchasing
acetaminophen over the counter. The scales were reviewed by the research team and simulated
patients were then trained to use these scales through the rehearsal of anticipated scenarios under
direct observation of the primary author. Friendliness was defined as not at all friendly (hostile with
a negative attitude, clear barrier to obtaining medication, does not provide any customer service or
conversation), minimally friendly (provides little assistance), moderately friendly (average customer
service, performs required duties), very friendly (more helpful than average, offers help without
prompting, provides better than average customer service), or extremely friendly (goes above and
beyond required duties, obviously committed to helping find the medication, excellent customer
service). Difficulty was defined as very easy (no hostility, smooth transaction, similar to buying OTC
acetaminophen), easy (minimal barriers to purchasing medication), difficult (some hostility, some
barriers to purchasing medication), or very difficult (very hostile environment, multiple barriers).
This study was approved by the University of Hawaii Human Subjects Board. The pharmacies
were unaware that these visits were occurring in order to create an authentic simulated patient
experience. A previously published ethical analysis concluded that simulated patient research without
consent is justified if risks are minimal and results can reveal meaningful knowledge [14].
Statistical analysis: IBM®SPSS statistical analysis software was used to conduct our data analysis.
Significance was set at a p-value of 0.05. Univariate analysis was performed for the following outcomes:
demographics of simulated patients, pharmacy characteristics, packaging, brands available, additional
information required, cost of medication, and staff members encountered. Chi-square analysis was
used to compare the following: availability at chain versus independent pharmacies, availability
at pharmacies in Honolulu versus outside of Honolulu, staff friendliness for female versus male
shopper encounters, and difficulty obtaining medication for female versus male shopper encounters.
Simulated patients’ comments on their experience were analyzed using a qualitative grounded
theory approach.
3. Results
Primary outcome measures: Of 109 chain pharmacies and 13 independent pharmacies, 102 (84%)
had LNG EC readily available OTC. The availability in chain versus independent pharmacies is shown
in Table 1. We did not see any differences between community, hospital, clinic, and Kaiser pharmacies.
The availability in Honolulu versus outside of Honolulu is shown in Table 2.
Table 1. Availability of levonorgestrel emergency contraception in chain versus independent pharmacies
on Oahu.
Pharmacy Type Available in Store N (%) P-Value
Yes No
0.49Chain 92 (84.4) 17 (15.6)
Independent 10 (76.9) 3 (23.1)
Table 2. Availability of levonorgestrel emergency contraception in pharmacies in Honolulu versus
outside Honolulu.
Pharmacy Type Available in Store N (%) P-Value
Yes No
0.03Honolulu 53 (91.4) 5 (8.6)
Outside Honolulu 49 (76.6) 15 (23.4)
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Secondary outcome measures: Plan B®was the most commonly available brand of LNG EC,
available at 82 (80.4%) of pharmacies, followed by Aftera®at 28 (27.5%) of pharmacies. The most
expensive brand of LNG EC was Plan B®, with a mean price of $50.99 (SD 5.58). The least expensive
option was EContraEZ®with a mean price of $22.70 (SD 5.40). Notably, this brand was only available
at Kaiser pharmacies and required Kaiser membership for purchase. Other brands included Next
Choice One Dose ™, My Way ®, Take Action ™, and Aftera ™.
The number of staff members experienced per encounter is shown in Table 3. The friendliness of
staff members is shown in Table 4. The packaging of medication is shown in Table 5. The difficulty
obtaining medication is shown in Table 6. The additional information required is shown in Table 7.
Table 3. Staff members experienced.
Number of StaffMembers Experienced N (%)
None 1 (1)
One 107 (88)
Two 13 (11)
Three 1 (1)
Table 4. Friendliness of staff members.
Friendliness N (%)
Not at all friendly 4 (3)
Minimally friendly 30 (25)
Moderately friendly 58 (48)
Very friendly 21 (17)
Extremely friendly 9 (7)
Table 5. Packaging of medication.
Availability N (%)
Over the counter 84 (69)
No packaging 46 (38)
Box on a shelf * 30 (25)
Large blister pack 4 (3)
Locked plastic box * 4 (3)
Out of stock 4 (3)
* Box on a shelf means a box that can be taken to the cashier and purchased. Locked plastic box means one that
needs to be unlocked by the cashier.
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Table 6. Difficulty obtaining medication.
Difficulty Level N (%)
Very easy 25 (21)
Easy 57 (47)
Difficult 17 (14)
Very difficult 1 (1)
Did not obtain 22 (18)
Willing to order * 9 (41)
Median number of days until available at store * 1
Unwilling to order * 13 (59)
* These are out of encounters where LNG EC was not obtained.
Table 7. Additional information required.
Additional Information N (%)
Age 3 (2)
ID 2 (2)
Prescription 1 (1)
Insurance card 9 (7)
During seven (5.7%) encounters, simulated patients were advised to seek the medication elsewhere
either for availability or a lower price. The median time taken to obtain LNG EC was 4 min (SD 3).
No differences were noted in encounters between female and male simulated patients.
Most encounters did not involve counseling. At a few pharmacy visits, inaccurate counseling
was provided. For example, one simulated patient was told that there was an age requirement for
purchasing LNG EC. At another encounter, a simulated patient was told that she needed to wait for
a pharmacist to be onsite for purchase in case she had questions about the medication. She was not
told when the pharmacist would be onsite. Other simulated patients had positive experiences where
they felt pharmacy staff went out of their way to help. This included offering generic brands and
explaining that they were the same medication or offering to check the patient’s insurance coverage for
a lower price.
4. Discussion
Our study found that 84% of pharmacies on Oahu had LNG EC available OTC. This is similar to the
national average of 83% based on previous studies [2]. While this is encouraging, more work needs to
be done to improve access to LNG EC. Although the medication is technically available OTC, pharmacy
practices may cause additional barriers. Large locked boxes, having to interact with staff members, and
not having generic brands available may contribute to the difficulty in obtaining LNG EC as compared
to other OTC medications, such as acetaminophen. The requirement to speak to a pharmacist may be
due to previous restrictions on age for purchase. This may also provide an opportunity for counseling
about other forms of contraception and sexually transmitted infection prevention. Recent studies
have shown the important role pharmacists play in patient counseling and the ability of pharmacy
students to confidentially counsel patients after an active-learning exercise [15,16]. However, patients
may encounter a pharmacist who has a personal moral objection to EC, as one of our simulated
patients did in a single encounter, which creates an additional access barrier. Not having generic
brands available likely relates to the limited shelf space of smaller pharmacies. Previous studies have
shown that some pharmacies do not stock EC due to the perception of low demand, pharmacy staff
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personal objection to EC, or store policy [17]. Our study found that 58% of pharmacies on Oahu
have LNG EC available OTC without a lock, which is higher than previous studies that show 22% of
pharmacies nationwide have LNG EC available without a lock [18]. Our study did not find a significant
difference in availability between chain versus independent pharmacies, which is contrary to previous
nationwide studies which found greater availability in chain pharmacies [18]. This could be due to
our smaller sample size. Due to Oahu’s geographic isolation, OTC availability may be even more
important than other parts of the country, as people have limited options for other pharmacies if their
local pharmacy does not have LNG EC readily available. The medication was much more available in
pharmacies in Honolulu as compared to outside of Honolulu. Distances between pharmacies outside
of Honolulu are greater than those within Honolulu. While LNG EC may be available at no or low
out-of-pocket cost to individuals through insurance pharmacy benefits, such purchases would require a
prescription and the documentation of insurance coverage, may require additional time and undesired
pharmacy staff contact, and may raise privacy concerns. Less than half of pharmacies without LNG
EC readily available were willing to order the medication and the median anticipated delay was one
day. This delay, while perhaps acceptable for other medications, has significant consequences for the
effectiveness of LNG EC and could potentially result in an unwanted pregnancy. Some simulated
patients experienced hostility where staff discouraged them from purchasing the medication or received
inaccurate counseling such as age requirements.
Previous studies have evaluated the knowledge of women regarding EC and cited this as a potential
barrier to timely access. A recent study assessed American female college students’ knowledge of EC
and found that some students were unclear about the timing, effectiveness, and side effects of EC [19].
Another study in the United States found that 44% of adolescents thought that EC could only be taken
within one day of intercourse to be effective [20]. This lack of knowledge extends to providers, with a
recent survey in Georgia showing that only 3% of providers knew the maximum window of efficacy
for EC [21]. This lack of knowledge is a potential additional barrier for women in Hawaii and future
studies should address EC knowledge among women and providers in Hawaii.
The strengths of our study include the in-person simulated patient methodology, which provided
data that best captured real-world patient experiences. Additionally, we visited every eligible pharmacy
on Oahu, thus eliminating the possibility of a sampling error.
A limitation of our study was the participation of only one male simulated patient. According to
FDA regulations, LNG EC should be made available to all consumers OTC, regardless of age or
sex [9]. Thus, males should be able to also purchase LNG EC OTC without additional barriers.
Another limitation was the subjective nature of some of our data collection, including friendliness
of staff and difficulty obtaining medication. While efforts were made to standardize these scales,
perception may have varied between simulated patients. Simulated patients did their best to present
themselves as reproductive aged men and women in need of emergency contraception; however, the
views and experiences of people in this situation are unique and may not have been reflected in our
simulated patients. As this study focused solely on pharmacies on the island of Oahu, our results may
not be generalizable to other islands in Hawaii, other parts of the United States, or other countries.
5. Conclusions
OTC access of LNG EC in Oahu pharmacies is similar to the national average; however, barriers
still remain. Given the time-sensitive nature of this medication, patient education and advance
prescription are essential. Pharmacy staff should receive expanded continuing education on LNG
EC, including the regulatory status of its OTC availability to all individuals regardless of age or sex.
This information should be a mandatory part of all undergraduate and ambulatory-focused graduate
pharmacy training programs. Pharmacy administrators should be encouraged to review their LNG EC
stocking practices to determine if barriers, such as locked boxes and blister packs, are indicated and
whether application of such barriers is consistently applied to other OTC medications. Further research
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is needed to determine patient and pharmacist’s perception of OTC medication barriers to assist in
formulating evidence-based recommendations for barrier reduction.
Supplementary Materials: The following are available online at http://www.mdpi.com/2226-4787/8/1/20/s1,
Data collection questionnaire and scales.
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